World Atopic Eczema Day The European Atopic Eczema Community comes together on World Atopic Eczema Day 2026, September 14th, to amplify the voices of those living with atopic eczema. Atopic eczema is one of the most prevalent skin diseases in the world and one of the most under-recognised. It affects over 230 million people globally, causing chronic pain as well as social, emotional and economic burdens,…
Detailsi-Alfa Training Now Available! Thalocan Research Innovations is proud to announce another collaboration with Dr. Arash Mostaghimi: i-ALFA – Investigator – Alopecia of the Lower Face Assessment – this is our fourth collaboration with Dr. Mostaghimi, the previous being The Severity of Alopecia Tool (SALT), The Brigham Eyebrow Tool for Alopecia (BETA) and the Brigham…
DetailsTwo new trainings on the way! Thalocan Research Innovations is excited to announce that we are in the final stages of post-production on two new expert-led trainings; EASI – The Eczema Area and Severity Index and vIGA-AD – The Validated Investigator Global Assessment for Atopic Dermatitis. Both of these trainings are led by Jonathan…
DetailsAugust is recognized annually as National Psoriasis Awareness Month. Key Facts About Psoriasis:What it is: A chronic autoimmune condition causing the immune system to overreact, speeding up skin cell growth. Appearance: Thick, red patches of skin covered with silvery-white scales that can itch, burn, or sting. Not contagious: It cannot be spread…
DetailsBuilt on Trust, Driven by Innovation A Conversation with Tyler WhiteSenior Director of Business Development, Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. Tyler White, Senior Director of Business Development More than Meets the Eye If you picture a business development executive, you probably do not picture someone spending weekends caring for a…
DetailsNOW AVAILABLE on the APP Store and Google Play: The Lesion Area Mapping Assistant (LAMA) is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical trials. Investigators can securely capture clinical images, map lesions, and document severity assessments using their own device or a study-provided tablet. LAMA enables real-time data sharing among investigators, CROs,…
DetailsOn behalf of our CEO Eric Zudak, all of us at Thalocan Research Innovations congratulate everyone at AAD on the success of the 2026 Innovation Academy. So grateful for the conversations, the insights and learning about all of the new breakthroughs in dermatology. We’ll see you again, next year!
Innovation. That’s what we’re about, too. Tomorrow, Thalocan Research Innovations CEO Eric Zudak begins four days at AAD innovation Academy 2026 – packed with the latest breakthroughs in dermatology, cutting-edge clinical insights and meaningful networking moments. Here at TRI we share this mindset of creating and sharing innovative and state-of-the-art technologies to assist physicians, trialists…
DetailsWith the release of several new and updated trainings in the coming weeks, Thalocan Research Innovations continues to establish itself as an industry leader for Investigator Training Content and Resources. Our standard and customized assessment training material is authored by globally recognized disease-specific key opinion leaders and experienced trialists. Our Creative Team enhances the content…
DetailsLooking forward to next week, when Thalocan Research Innovations CEO Eric Zudak heads to 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology. The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. And when it comes to cutting edge, TRI is proud to deliver TRICOA, the first…
Details
